Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Paragangliomas: clinical overview.

William F Young1

  • 1Division of Endocrinology, Diabetes, Metabolism, Nutrition, and Internal Medicine, Mayo Clinic, 200 First Street S.W. Rochester, MN 55905, USA. Young.William@Mayo.edu

Annals of the New York Academy of Sciences
|November 15, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety of biopsy in phaeochromocytoma and paraganglioma: an international, multicentre, retrospective cohort study.

The lancet. Diabetes & endocrinology·2026
Same author

Adrenal histologic and genetic characteristics of primary aldosteronism in late adulthood.

European journal of endocrinology·2026
Same author

Endocrine and metabolic determinants of cardiometabolic risk in mild autonomous cortisol secretion.

EBioMedicine·2026
Same author

Cardiometabolic Outcomes after Surgical Remission of Endogenous Hypercortisolism: A Prospective Cohort Study.

The Journal of clinical endocrinology and metabolism·2025
Same author

Duration of adrenal insufficiency after surgical treatment of endogenous hypercortisolism: a prospective cohort study.

European journal of endocrinology·2025
Same author

A comparison of bilateral internal jugular vein sampling with bilateral inferior petrosal sinus sampling at Mayo Clinic for the subtype evaluation of corticotropin-dependent cushing syndrome.

Pituitary·2025
Same journal

Multiomics Profiling During Autoimmune Demyelination Highlights a Complex Regulatory Role for Ataxin-1 in B Cells.

Annals of the New York Academy of Sciences·2026
Same journal

Global Trends in Light Pollution and Their Relationship With Socioeconomic Factors.

Annals of the New York Academy of Sciences·2026
Same journal

Wired for Corruption: Inter-Brain Synchrony Encodes Bribery-Related Value Information and Predicts Bribery Agreement.

Annals of the New York Academy of Sciences·2026
Same journal

LM-YOLO: A Lightweight Multi-Scale Enhanced Model for Forest Smoke Detection Using Unmanned Aerial Vehicles.

Annals of the New York Academy of Sciences·2026
Same journal

Polyrhythm Perception and Production: A Scoping Review.

Annals of the New York Academy of Sciences·2026
Same journal

DARTS-CNN-BiLSTM: Intelligent Fault Diagnosis for Computer Numerical Control Machine Tool Feed System.

Annals of the New York Academy of Sciences·2026
See all related articles

Paragangliomas are rare tumors often linked to hereditary conditions. Early diagnosis through biochemical testing and genetic screening, followed by surgical resection, is key for effective management and monitoring for recurrence.

Area of Science:

  • Endocrinology
  • Oncology
  • Genetics

Background:

  • Paragangliomas are rare tumors originating from extra-adrenal paraganglia.
  • Diagnosis involves multidisciplinary collaboration for patients presenting with catecholamine hypersecretion, mass effect, incidental findings, or family screening.
  • Symptoms of catecholamine-secreting paragangliomas mimic those of pheochromocytoma.

Purpose of the Study:

  • To outline the diagnostic and management strategies for paraganglioma patients.
  • To emphasize the importance of biochemical testing preceding imaging for suspected catecholamine-secreting tumors.
  • To highlight the hereditary nature of paragangliomas and the role of genetic testing.

Main Methods:

  • Biochemical documentation of catecholamine and fractionated metanephrine hypersecretion.

Related Experiment Videos

  • Imaging studies to locate tumors where chromaffin tissue is present.
  • Genetic testing for hereditary paraganglioma syndromes.
  • Surgical resection as the primary treatment modality.
  • Annual biochemical testing post-surgery to monitor for recurrence or metastatic disease.

    • Main Results:

    • Catecholamine-secreting paragangliomas can occur in various locations with chromaffin tissue.
    • Up to 50% of paragangliomas are hereditary, associated with several genetic syndromes.
    • Surgical resection is effective for most benign paragangliomas.
    • Post-treatment surveillance is crucial for detecting metastasis or new tumors.

    Conclusions:

    • Effective paraganglioma management requires a multidisciplinary approach.
    • Biochemical testing is essential for diagnosing catecholamine-secreting tumors.
    • Genetic testing and surgical resection are vital components of care.
    • Long-term biochemical monitoring is necessary after treatment.